SP
Sumati Pradhan Paik
About Sumati Pradhan Paik
Sumati Pradhan Paik has 5 years in corporate governance. Holds Director role. Currently with 2 companies, including Cherify Pharmaceuticals Private Limited and Cherify Care Foundation. Formerly with 2 companies, such as Magiccrop Home Care Private Limited and Magiccrop Business Private Limited. Engaged in General Business. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Cherify Pharmaceuticals Private Limited
U21000WB2025PTC278479
|
Director | 16 Apr 2025 | 2025 | Active |
Cherify Care Foundation
U88900WB2025NPL276188
|
Director | 30 Jan 2025 | 2025 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Magiccrop Home Care Private Limited
U20233WB2023PTC263043
|
Director | 26 Jun 2023 | 2023 | Active |
Magiccrop Business Private Limited
U01114WB2020PTC239050
|
Director | 21 Aug 2020 | 2020 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sumati Pradhan Paik
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sumati Pradhan Paik
Sumati Pradhan Paik has 5 years in corporate governance. Holds Director role. Currently with 2 companies, including Cherify Pharmaceuticals Private Limited and Cherify Care Foundation. Formerly with 2 companies, such as Magiccrop Home Care Private Limited and Magiccrop Business Private Limited. Engaged in General Business. Contributes to corporate operations.
Sumati Pradhan Paik is associated with 2 companies as Director.
Sumati Pradhan Paik has expertise in General Business.
Sumati Pradhan Paik has 5 years in corporate governance.